Primary Intravenous Set Consumption Across 3 Branded Infusion Pumps

Nancy Hedlund¹, Shishir Sarangpur, Shannon Kayler+2

• ¹Baxter Healthcare Corporation, Deerfield, Illinois (Ms Kayler, Ms O'Brien, and Dr Beer); Creativ-Ceutical, Chicago, Illinois (Mr Sarangpur); and health economics and outcomes research independent consultant, Libertyville, Illinois (Ms Hedlund). Nancy Hedlund, MBA, BSPharm, is a PhD candidate in public health sciences at the University of Illinois, Chicago, and an independent consultant in health economics and outcomes research. At the time of this study she was associate director, Global Health Economics and Outcomes Research at Baxter Healthcare Corporation. She previously provided informatics support for Deloitte; led a consultant team at Hospira, Inc, responsible for intravenous medication systems; and practiced professionally as a pharmacist. Shishir Sarangpur, MS, BSPharm, is a research analyst at Creativ-Ceutical and has a background as a pharmacist. He is experienced in health outcomes/comparative effectiveness research and economic modeling, including in vascular thromboembolism, breast cancer, hyperlipidemia, and diabetes. Previously, he was a research technologist in pharmacy practice at the University of Illinois and an intern at Takeda Pharmaceuticals. Shannon Kayler, BSN, RN, is a senior clinical manager at Baxter Healthcare. She continues to practice as a hospital operating room nurse a few days a month. She participates in human factors studies and in design and deployment of Baxter products for the global marketplace. Before coming to Baxter, she practiced in the operating room, as well as in the postanesthesia care unit. Kathy O'Brien, MSN, RN, APRN-BC, is a senior clinical services manager with Baxter Healthcare's Clinical Center of Excellence. She has more than 25 years of hospital experience in medical-surgical nursing and more than 10 years of experience as a nurse consultant in the medical device industry. She maintains American Nurses Credentialing Center certification as an adult health clinical nurse specialist. Idal Beer, MD, MBA, MPH, is global medical director, therapeutic area lead, at Baxter Healthcare Corporation. His background is in internal medicine and critical care medicine. His interests are in the areas of techniques and technologies intended to reduce bloodstream infections, medication errors, and costs associated with intravenous therapy.